Lídia M. Gonçalves
PhD (1993) in Biological Engineering (Microbial Technology), Universidade Nova de Lisboa
Invited Assistant Professor at Departamento de Farmácia Galénica e Tecnologia Farmacêutica
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
Lídia Gonçalves is a team member of the NanoBB group. Gonçalves works focused on the development of new 3D systems (micro/nano structures) for drug delivery, including drug stabilization and targeting. Her research also involves antigen delivery using particulate adjuvants for modulating the immune response to complex antigens, as well as enhancing local immunity.
Gonçalves expertise on in vitro high-throughput biological assays, biotechnological process and animal experimentation has allowed the establishment of collaboration work within iMed.ULisboa and also with other external research groups. This collaborating work has been protected by patents.
Silva MM, Calado R, Marto J, Bettencourt A, Almeida AJ, Gonçalves LMD. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration. Mar Drugs 2017; 15: 370.
Graça D, Louro H, Santos, Santos J, Dias K, Gonçalves L, Almeida A, Silva MJ, Bettencourt AF . Toxicity screening of novel poly(methylmethacrylate) nanocarriers on L929 fibroblast cells. Toxicology Letters 2017; 276:129-137.
Gaspar DP, Gaspar MM, Eleuterio CV, Grenha A, Blanco M, Goncalves LMD, Taboada P, Almeidab AJ, Remunan-Lopez C. Microencapsulated solid lipid nanoparticles as a hybrid platform for pulmonar antibiotic delivery. Mol. Pharmaceutics 2017; 14: 2977–2990.
Caetano LA, Figueiredo L, Almeida AJ, Gonçalves LMD. (). BCG-loaded chitosan microparticles: Interaction with macrophages and preliminary in vivo studies. J Microencapsulation 2017; 34: 203-217.
Caetano LA, Almeida AJ, Goncalves LMD. Approaches to tuberculosis mucosal vaccine development using nano and microparticles: a review. J Biomed Nanotechnol 2014; 9, 2295-2316.